These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21500491)

  • 61. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC; Elhilali M; Emberton M; Vallancien G;
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Re: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
    Kaplan SA
    J Urol; 2013 Sep; 190(3):978. PubMed ID: 23931214
    [No Abstract]   [Full Text] [Related]  

  • 63. [Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia].
    Neĭmark AI; Nozdrachev NA
    Urologiia; 2013; (4):47-8, 50-1. PubMed ID: 24159765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Combined treatment of patients with lower urinary tract symptoms and erectile dysfunction].
    Tomilov AA; Golubtsova EN
    Urologiia; 2013; (5):64-6, 68-9. PubMed ID: 24437244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?
    Morgia G
    Eur Urol; 2011 Mar; 59(3):353-5; discussion 355. PubMed ID: 21130562
    [No Abstract]   [Full Text] [Related]  

  • 66. Should you take an erectile dysfunction drug to also ease urinary woes? We think not. Standard medications to treat the symptoms of an enlarged prostate are still the best first choice for men.
    Harv Mens Health Watch; 2013 Jun; 17(11):1, 7. PubMed ID: 24000418
    [No Abstract]   [Full Text] [Related]  

  • 67. Monotherapy for comorbid erectile dysfunction and lower urinary tract symptoms: phosphodiesterase inhibitor or α-adrenoceptor antagonist?
    Wyllie MG
    BJU Int; 2012 Apr; 109(7):965-6. PubMed ID: 22373009
    [No Abstract]   [Full Text] [Related]  

  • 68. Editorial comment from Dr Funahashi to α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: efficacy of dose increase therapy.
    Funahashi Y
    Int J Urol; 2013 May; 20(5):521. PubMed ID: 23131001
    [No Abstract]   [Full Text] [Related]  

  • 69. Editorial comment from Dr Ishizuka to α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: efficacy of dose increase therapy.
    Ishizuka O
    Int J Urol; 2013 May; 20(5):520. PubMed ID: 23078593
    [No Abstract]   [Full Text] [Related]  

  • 70. Editorial comment from Dr Park to α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: efficacy of dose increase therapy.
    Park WH
    Int J Urol; 2013 May; 20(5):519-20. PubMed ID: 23078577
    [No Abstract]   [Full Text] [Related]  

  • 71. Silodosin: erectile and ejaculatory disorders.
    Prescrire Int; 2012 May; 21(127):129. PubMed ID: 22844684
    [No Abstract]   [Full Text] [Related]  

  • 72. Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms.
    Andersson KE
    BJU Int; 2000 Apr; 85 Suppl 2():12-8. PubMed ID: 10781180
    [No Abstract]   [Full Text] [Related]  

  • 73. Natural therapies used by adult men for the treatment of erectile dysfunction, benign prostatic hyperplasia, and for augmenting exercise performance.
    Evans JD; Pace K; Evans EW
    J Pharm Pract; 2011 Jun; 24(3):323-31. PubMed ID: 21676856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Our experience with the use of alpha-lithic therapy in the treatment of voiding dysfunction].
    Delgado Alvira R; Calleja Aguayo E; Rihuete Heras MA; Ruiz de Temiño Bravo M; Gracia Romero J
    Cir Pediatr; 2010 Oct; 23(4):197-200. PubMed ID: 21520549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Re: Christopher R. Chapple, Francesco Montorsi, Teuvo L.J. Tammela, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 2011;59:342-52.
    Yang SS; Chang SJ
    Eur Urol; 2011 Aug; 60(2):e11; author reply e12-3. PubMed ID: 21565442
    [No Abstract]   [Full Text] [Related]  

  • 76. [Drug therapy in patients with adenoma of the prostate gland with urination disorders].
    Spivak LG; Vinarov AZ; Evdokimov MS
    Urologiia; 2012; (6):96-9. PubMed ID: 23379250
    [No Abstract]   [Full Text] [Related]  

  • 77. Sexual dysfunction in patients with benign prostatic hyperplasia.
    Downs TM; O'Leary MP
    Curr Opin Urol; 1999 Jan; 9(1):9-14. PubMed ID: 10726066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current view and status of the treatment of lower urinary tract symptoms and neurogenic lower urinary tract dysfunction.
    Kakizaki H; Koyanagi T
    BJU Int; 2000 Apr; 85 Suppl 2():25-30. PubMed ID: 10781182
    [No Abstract]   [Full Text] [Related]  

  • 79. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study].
    Dörner G; Fritsche C
    ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081
    [No Abstract]   [Full Text] [Related]  

  • 80. [Dignosis of functional disorders of the lower urinary tract in prostatic adenoma].
    Pasechnikov AP
    Klin Khir (1962); 1976 Sep; 00(9):51-3. PubMed ID: 62077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.